'World-first' vaccine designed by artificial intelligence
Summary
Cambridge researchers have utilized artificial intelligence to design a 'super-antigen' capable of training the human immune system to protect against entire families of coronaviruses, including future mutations. By analyzing vast amounts of genetic data from known viral threats, the AI identified components that standard human analysis might miss. Early clinical trials involving 39 participants indicate the vaccine is safe, with further studies planned to assess its efficacy. Experts believe this technology represents a fundamental shift in pandemic preparedness, potentially enabling faster development of vaccines for diseases like bird flu and Ebola.
(Source:BBC News)